Article

Dry eye diagnostic coming to a clinic near you

OcuSense, makers of the innovative TearLab Osmolarity System for the diagnosis of dry eye, announced the signing of multi-year agreements with four distributors in five EU countries, for the exclusive distribution of the TearLab system.

OcuSense, makers of the innovative TearLab Osmolarity System for the diagnosis of dry eye, announced the signing of multi-year agreements with four distributors in five EU countries, for the exclusive distribution of the TearLab system.

The countries involved include: the UK and Ireland (Birmingham Optical Group); Germany (bon Optic), Spain (Equipsa); and Italy (SIFI Diagnostics).

The TearLab System determines osmolarity through measurement of electrical impedance of tear samples. It uses a lab-on-a-chip approach: the disposable tip not only takes the tiny tear film samples, less than 50 nL, from the eye but also contains electrodes that rapidly measure tear osmolarity. It takes about 30 seconds to perform the test from start to finish, and can be done by a technician. Thus the test can be easily performed in the office and only a tiny tear sample is required.

A multicentre study with the system is scheduled to begin later this year in six European sites: the UK, Germany, France, Italy, and Spain, as well as three sites in the US and one in Japan.

Related Videos
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.